Chemopreventative Effect of Hochu-ekki-to (TJ-41) on Chemically Induced Biliary Carcinogenesis in Hamsters

Journal of Surgical Research

Volumn 151, Issue 1, 2009, Pages 22-27

  Tsuneoka, Noritsugu ^a   Tajima, Yoshitsugu ^a   Kitasato, Amane ^a   Fukuda, Kenzo ^a   Kitajima, Tomoo ^a   Adachi, Tomohiko ^a   Mishima, Takehiro ^a   Kuroki, Tamotsu ^a   Onizuka, Shinya ^a   Kanematsu, Takashi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

biliary carcinoma; chemoprevention; Hochu ekki to; TJ 41

Indexed keywords

BIS(2 OXOPROPYL)NITROSAMINE; BU ZHONG YI QI TANG; CYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT CARCINOMA; CANCER PREVENTION; CARCINOGENESIS; CELL KINETICS; CHEMOPROPHYLAXIS; CHOLANGITIS; CHOLEDOCHOJEJUNOSTOMY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENTEROSTOMY; FEMALE; HAMSTER; HERBAL MEDICINE; HISTOPATHOLOGY; JEJUNOSTOMY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL PROLIFERATION; CHOLEDOCHOSTOMY; CRICETINAE; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; EPITHELIAL CELLS; FEMALE; INJECTIONS, SUBCUTANEOUS; MESOCRICETUS; NITROSAMINES; PHYTOTHERAPY;

EID: 57149108978     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.01.003     Document Type: Article

References (37)

1. Tocchi A., Costa G., Lepre L., et al. The long-term outcome of hepaticojejunostomy in the treatment of benign bile duct strictures. Ann Surg 224 (1996) 162
2. Rothlin M.A., Lopfe M., Schlumpf R., et al. Long-term results of hepaticojejunostomy for benign lesions of the bile ducts. Am J Surg 175 (1998) 22
3. Saing H., Han H., Chan K.L., et al. Early and late results of excision of choledochal cysts. J Pediatr Surg 32 (1997) 1556
4. Uno K., Tsuchida Y., Kawarazaki H., et al. Development of intrahepatic cholelithiasis long after primary excision choledochal cysts. Am Coll Surg 183 (1996) 583
5. Coyle K.A., and Bradley E.L. 3d. Cholangiocarcinoma developing after simple excision of type II choledochal cyst. South Med J 85 (1992) 540
6. Watanabe Y., Toki A., and Todani T. Bile duct cancer developed after cyst excision for choledochal cyst. J Hepato Biliary Pancr Surg 6 (1999) 207
7. Strong R.W. Late bile duct cancer complicating biliary-enteric anastomosis for benign disease. Am J Surg 177 (1999) 472
8. Tocchi A., Mazzoni G., Liota G., et al. Late development of bile duct cancer in patients who had biliary-enteric drainage for benign disease: A follow-up study of more than 1,000 patients. Ann Surg 234 (2001) 210
9. Kitajima T., Tajima Y., Onizuka S., et al. Linkage of persistent cholangitis after bilioenterostomy with biliary carcinogenesis in hamster. J Exp Clin Cancer Res 19 (2000) 453
10. Kitajima T., Tajima Y., Matsuzaki S., et al. Acceleration of spontaneous biliary carcinogenesis in hamsters by bilioenterostomy. Carcinogenesis 24 (2003) 133
11. Kim S.H., Lee S.E., Oh H., et al. The radioprotective effects of bu-zhong-yi-qi-tang: A prescription of traditional Chinese medicine. Am J Chin Med 30 (2002) 127
12. Kaneko M., Kawakita T., Kumazawa Y., et al. Accelerated recovery from cyclophosphamide-induced leukopenia in mice administered a Japanese ethical herbal drug, Hochu-ekki-to. Immunopharmacol 44 (1999) 223
13. Cho J.M., Sato N., and Kikuchi K. Prophylactic anti-tumor effect of Hochu-ekki-to (TJ41) by enhancing natural killer cell activity. In Vivo 5 (1991) 389
14. Ohnishi Y., Fujii H., Hayakawa Y., et al. Oral administration of a kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells. Jpn J Cancer Res 9 (1998) 206
15. Utsuyama M., Seidlar H., Kitagawa M., et al. Immunological restoration and anti-tumor effect by Japanese herbal medicine in aged mice. Mech Ageing Dev 122 (2001) 341
16. Onishi Y., Yamaura T., Tauchi K., et al. Expression of the anti-metastatic effect induced by Juzen-taiho-to is based on the content of Shimotsu-to constituents. Biol Pharm Bull 21 (1998) 761
17. Harada M., Seta K., Ito O., et al. Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang). Immunopharmacol Immunotoxicol 17 (1995) 687
18. Kao S.T., Yeh C.C., Hsieh C.C., et al. The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest. Life Sci 69 (2001) 1485
19. Zhu K., Fukasawa I., Furuno M., et al. Inhibitory effects of herbal drugs on the growth of human ovarian cancer cell lines through the induction of apoptosis. Gynecol Oncol 97 (2005) 405
20. Onogi K., Niwa K., Tang L., et al. Inhibitory effects of Hochu-ekki-to on endometrial carcinogenesis induced by N-methyl-N-nitrosourea and 17beta-estradiol in mice. Oncol Rep 16 (2006) 1343
21. Takahashi M., Pour P., Althoff J., et al. The pancreas of the Sylian hamster (Mesocricetus auratua). Lab Anim Sci 27 (1977) 336
22. Singhal A.K., Sadowsky J.F., McSherry C.K., et al. Effect of cholesterol and bile acids on the regulation of cholesterol mechanism in hamster. Biochem Biophy Acta 752 (1983) 214
23. Rinderknecht H., Maset R., Collias K., et al. Pancreatic secretory profiles of protein, digestive, and lysosomal enzymes in Sylian golden hamster. Effect of secretin and cholecystokinin. Dig Dis Sci 28 (1983) 518
24. Pour P., Althoff J., Kruger F.W., et al. A potent pancreatic carcinogen in Syrian hamster: N-nitrosobis(2-oxopropyl)amine. J Natl Cancer Inst 58 (1977) 1449
25. Tajima Y., Eto T., Tsunoda T., et al. Induction of extrahepatic biliary carcinoma by N-nitrosobis(2-oxopropyl)amine in hamsters given cholecystoduodenostomy with dissection of the common duct. Jpn J Cancer Res 85 (1994) 780
26. Moore M.A., Thamavit W., and Bannasch P. Tumours of the liver. In: Turusov V.S., and Mohr U. (Eds). Pathology of tumours in laboratory animals, vol. 3, Tumours of the hamster. 2 ed. (1996), International Agency for Research on Cancer, Lyon 79-108
27. Fukuda K., Kuroki T., Tajima Y., et al. Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis 23 (2002) 1927
28. Ohta T., Nagakawa T., Ueda N., et al. Mucosal dysplasia of the liver and the intraductal variant of peripheral cholangiocarcinoma in hepatolithiasis. Cancer 68 (1991) 2217
29. Falchuk K.R., Lesser P.B., Galdabini J.J., et al. Cholangiocarcinoma as related to chronic intrahepatic cholangitis and hepatolithiasis. Case report and review of the literature. Am J Gastroenterol 66 (1976) 57
30. Chijiiwa K., Ichimiya H., Kuroki S., et al. Late development of cholangiocarcinoma after the treatment of hepatolithiasis. Surg Gynecol 177 (1993) 279
31. Holzinger F., Z'graggen K., and Büchler M.W. Mechanisms of biliary carcinogenesis: A pathogenetic multi-stage cascade towards cholangiocarcinoma. Ann Oncol 10 (1999) 122
32. Chapman R.W. Risk factors for biliary tract carcinogenesis. Ann Oncol 10 (1999) 308
33. Taniai M., Higuchi H., Burgart L.J., et al. p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma. Gastroenterology 123 (2002) 1090
34. Tsuneoka N., Tajima Y., Kitazato A., et al. Chemopreventative effect of a cyclooxygenase-2-specific inhibitor (etodolac) on chemically induced biliary carcinogenesis in hamsters. Carcinogenesis 26 (2005) 465
35. Mori K., Kido T., Daikuhara H., et al. Effect of hochu-ekki-to (TJ-41), a Japanese herbal medicine, on the survival of mice infected with influenza virus. Antiviral Res 44 (1999) 103
36. Hai le X., Kogure T., Niizawa A., et al. Suppressive effect of hochu-ekki-to on collagen induced arthritis in DBA1J mice. J Rheumatol 29 (2002) 1601
37. Furuya Y., Akashi T., and Fuse H. Effect of Bu-zhong-yi-qi-tang on seminal plasma cytokine levels in patients with idiopathic male infertility. Arch Androl 50 (2004) 11